ReviewThe FEBS journal2019
Advances and challenges in targeting IRF5, a key regulator of inflammation.
Hannah Almuttaqi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
65 papers cite itlatest 60 shown
this papercites it
ReviewThe FEBS journal2019
Hannah Almuttaqi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.